MAPK1 and lung cancer: This showed that the activation of the PI3K/Akt/ERK signaling pathway antagonizes sinomenine-induced lung cancer cell apoptosis, and molecules that inhibit these pathways were expected to further improve the inhibitory effects of sinomenine.